Northern Trust
PROK icon

Northern Trust’s ProKidney PROK Stock Holding History

Northern Trust’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
664,827
+423,247
+175% +$775K ﹤0.01% 3346
2026
Q1 		$432K Hold
241,580
– – ﹤0.01% 3667
2025
Q4 		$541K Buy
241,580
+51,528
+27% +$136K ﹤0.01% 3630
2025
Q3 		$460K Sell
190,052
-61,334
-24% -$163K ﹤0.01% 3678
2025
Q2 		$149K Sell
251,386
-655,832
-72% -$511K ﹤0.01% 4020
2025
Q1 		$795K Buy
907,218
+16,311
+2% +$22.6K ﹤0.01% 3379
2024
Q4 		$1.51M Buy
890,907
+61,206
+7% +$110K ﹤0.01% 3174
2024
Q3 		$1.59M Buy
829,701
+486,693
+142% +$1.1M ﹤0.01% 3134
2024
Q2 		$844K Sell
343,008
-6,349
-2% -$17K ﹤0.01% 3316
2024
Q1 		$573K Sell
349,357
-29,861
-8% -$43.9K ﹤0.01% 3521
2023
Q4 		$675K Buy
379,218
+593
+0.2% +$1.27K ﹤0.01% 3443
2023
Q3 		$1.73M Sell
378,625
-73,561
-16% -$704K ﹤0.01% 3022
2023
Q2 		$5.06M Buy
452,186
+423,043
+1,452% +$4.5M ﹤0.01% 2492
2023
Q1 		$330K Buy
29,143
+1,071
+4% +$11.4K ﹤0.01% 3624
2022
Q4 		$193K Buy
28,072
+9,370
+50% +$89.5K ﹤0.01% 3889
2022
Q3 		$169K Buy
+18,702
New +$163K ﹤0.01% 3941

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust's PROK Position: Q2 2026 in Review

Northern Trust increased its ProKidney (PROK) stake by 175% in Q2 2026, buying an estimated $775K and bringing the position to 664,827 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3346.

Northern Trust first reported a position in PROK in Q3 2022 and has held it in 16 quarters since. The position peaked at $5.06M in Q2 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Northern Trust held 664,827 shares of ProKidney worth $1.36M as of Q2 2026.
  • Northern Trust bought 423,247 ProKidney shares in Q2 2026, an estimated $775K.
  • ProKidney made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3346 holding.
  • Northern Trust first reported a position in ProKidney in Q3 2022 and has held it in 16 quarters since.
  • Northern Trust's ProKidney position peaked at $5.06M in Q2 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.